key: cord-0787307-ffwlpx8s
authors: Rai, Deependra Kumar; Kumar, Rahul; Pandey, Sanjay Kumar
title: Problems faced by tuberculosis patients during COVID-19 pandemic: Urgent need to intervene
date: 2020-07-21
journal: Indian J Tuberc
DOI: 10.1016/j.ijtb.2020.07.013
sha: 335d0c1239d7eddf5e9ca04ec3fe96b084d24f74
doc_id: 787307
cord_uid: ffwlpx8s

• Highlight of study. • This is first survey who assessed problem faced by tuberculosis patient during this lockdown. • This survey highlights that, almost one fifth patient (17.33%) defaulted tuberculosis treatment due to lockdown as they could not get the medicine. • Another one fifth (20.96%) required purchasing the medicine from private pharmacy despite of started on Government supplied FDC preparation. • Restricting themselves to home as preventive measures was practised by 91(66.66%) patients while 21(14%) patients use mask and 15(10%) patients use hand washing only as measures to avoid the corona infection.

Sir Coronavirus disease (COVID-19) is an infectious disease caused by novel coronavirus named as SARS Cov-2. It originated in the city of Wuhan, the capital of Hubei province of China in December 2019 and has been declared pandemic by the World Health Organisation [1] [2] . The disease has now spread in more than 200 countries and even our country has been badly affected. More than 85000 cases and more than 2500 deaths have occurred till date (15 th May 2020). Honourable Prime Minister announced a 'Janta curfew' on 22nd March 2020. Thereafter, a nationwide 'Lockdown' was ordered which has been effective in slowing down the growth rate of pandemic.

The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions and has adversely affected the management of other diseases. Tuberculosis (TB) is the world's biggest killer among infectious diseases, claiming more than 4000 lives each day. India has the greatest number of both drug sensitive and drug resistant TB [3] . Patients who are under treatment from tertiary care hospital are badly affected due to lockdown implemented to contain coronavirus infection.

Primary objective of the study is to assess the difficulty faced by TB patients due to lockdown implemented to contain the coronavirus infection.

Patients getting treatment for drug sensitive pulmonary or extra-pulmonary tuberculosis who were in the intensive phase of treatment from AIIMS-Patna were included for survey. Anti-tubercular drugs (4FDC+3FDC) were provided by the Government at our centre. We developed oral questionnaire which included 7 questions to assess the problems faced by TB patients. Response to each question was recorded as dichotomous variable (Yes/No).

The survey was conducted telephonically by the Upper divisional clerk of our department. Out of 175 patients, survey could be conducted in 150 patients (73 male and 77 female) as the call was not responded in remaining 25 patients. The result of the survey is summarised in Table 1. 26 (17.33%) out of 150 patients defaulted treatment as they could not come to their primary treatment or couldn't get the medicine from local health centre due to lockdown. This is a terrifying scenario as these patients continue to disseminate infection. It may also lead to treatment failure and emergence of drug resistant TB. Among 124 patients taking anti-tubercular drugs, 26 (20.96%) patients purchased the medicine from private pharmacy while 98 (79.03%) patients were getting government supplied drugs, either from primary treating centre (37.75%)) or local health centre (62.24%).

Almost one third, 44 (29.33%) patients visited the institute but could not succeed in getting consultation as outpatient department was closed. 37 (84%) among these patients used their own vehicle to visit the institute. 13 There are certain suggestions by STOP-TB partnership in this COVID-19 pandemic era for better care of TB patients. There should be proper communication with people affected by TB and all stakeholders using virtual means of communication. They should be provided with anti-tubercular drugs for at least two months. Anti-tubercular drug availability should be ensured at every level and properly monitored. TB care providers should be well briefed and use essential personal protection equipment.

This survey highlights that, almost one fifth patient (17.33%) defaulted tuberculosis treatment due to lockdown as they could not get the medicine and one fifth (20.96%) required purchasing the medicine from private pharmacy. Most of the patients agree that restrictive themselves is the most effective strategy to avoid infection by corona infection. There should be adequate coordination and communication among all those involved with treatment of TB patients. 

China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China

Burki Coronavirus in China

Highlight of study 1. This is first survey who assessed problem faced by tuberculosis patient during this lockdown 2. This survey highlights that, almost one fifth patient (17.33%) defaulted tuberculosis treatment due to lockdown as they could not get the medicine 3. Another one fifth (20.96%) required purchasing the medicine from private pharmacy despite of started on Government supplied FDC preparation 4. Restricting themselves to home as preventive measures was practised by 91(66.66%) patients while 21(14%) patients use mask and 15(10%) patients use hand washing only as measures to avoid the corona infection.

Journal Name: Indian Journal of tuberculosis

Manuscript id: IJTB 478 IJTB follows the ICMJE recommendations regarding conflict of interest disclosures. All authors are required to report the following information with each submission: (1) All third-party financial support for the work in the submitted manuscript. (2) All financial relationships with any entities that could be viewed as relevant to the general area of the submitted manuscript.(3) All sources of revenue with relevance to the submitted work who made payments to you, or to your institution on your behalf, in the 36 months prior to submission. (4) Any other interactions with the sponsor of outside of the submitted work should also be reported. (5) Any relevant patents or copyrights (planned, pending, or issued). (6) Any other relationships or affiliations that may be perceived by readers to have influenced, or give the appearance of potentially influencing, what you wrote in the submitted work. As a general guideline, it is usually better to disclose a relationship than not. This information will be acknowledged at publication in a Transparency Document link directly in the article. Additional information on the ICMJE recommendations can be found at: http://www.icmje.org/. The form for conflict of interest disclosure can be downloaded here: http://www.icmje.org/coi_disclosure.pdf (if this link does not display properly in your browser, please right-click the link and select "Save Target As..." or "Save Link as..." from the pop-up menu).